Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
0,06 CAD | +9,09% | +9,09% | +200,00% |
Attività
Vendite per attività
CAD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Nutraceutical and Pharmaceutical Products
100,0
%
| 0 | nan % | 0 | 100,0 % | - |
Vendite per regione
CAD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Canada
100,0
%
| 0 | nan % | 0 | 100,0 % | - |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Sina Pirooz
CEO | Chief Executive Officer | 55 | 11/03/19 |
Mahmoud Aziz
CHM | Chairman | - | 19/05/21 |
Danny Lee
DFI | Director of Finance/CFO | - | 14/12/20 |
Kevin Bottomley
BRD | Director/Board Member | 45 | 05/09/19 |
Jamie Lewin
BRD | Director/Board Member | 74 | 11/03/19 |
Buckley Dodds
AUD | Comptroller/Controller/Auditor | - | 26/05/23 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Danny Lee
DFI | Director of Finance/CFO | - | 14/12/20 |
Jamie Lewin
BRD | Director/Board Member | 74 | 11/03/19 |
Mahmoud Aziz
CHM | Chairman | - | 19/05/21 |
Paul Chow
BRD | Director/Board Member | 59 | - |
Kevin Bottomley
BRD | Director/Board Member | 45 | 05/09/19 |
Sina Pirooz
CEO | Chief Executive Officer | 55 | 11/03/19 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 59 224 131 | 33 550 348 ( 56,65 %) | 0 | 56,65 % |
Coordinate società
Genix Pharmaceuticals Corp.
1055 West Hastings Street Suite 300
V6E 2E9, Vancouver
+604-609-6198
http://www.genixpharm.comSettore
Variaz. 1 gen. | Capi. | |
---|---|---|
+200,00% | 2,6 Mln | |
+8,20% | 7,78 Mrd | |
+0,34% | 7,38 Mrd | |
+10,20% | 6,52 Mrd | |
-8,10% | 3,67 Mrd | |
-14,57% | 1,17 Mrd | |
+8,34% | 934 Mln | |
-42,27% | 879 Mln | |
-18,90% | 836 Mln | |
-16,45% | 802 Mln |
- Borsa valori
- Azioni
- Azione GENX
- Società Genix Pharmaceuticals Corporation